Inovio to present DNA medicine research at scientific conferences

INO•2026-11-02

Inovio will present DNA-based protein replacement therapeutics at a hypophosphatasia scientific meeting in New York on Nov. 8, 2026, and INO-D001 for hemophilia A at a workshop in Montreal on Nov. 12, 2026.

1. Conference presentations

Inovio will present DNA-based protein replacement therapeutics at the Soft Bones hypophosphatasia scientific meeting in New York on Nov. 8, 2026. It will present INO-D001 for hemophilia A at the World Federation of Hemophilia’s NTGT Workshop in Montreal on Nov. 12, 2026.

Inovio to present DNA medicine research at scientific conferences

1. Conference presentations

Related News

Cooper-Standard estimates $215 million in U.S. tax benefits as of Sept. 30, 2026

Gelteq delays annual report to finalize financial statements

Diamondback Energy beats profit estimates as Iran war lifts oil prices

Williams files for resale of up to 26,874,496 common shares

Align Technology files initial beneficial ownership statement for CEO-elect and director Jennifer L. Davis